(Q39530259)

English

Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation

scientific article published on August 1, 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Histone Deacetylase Inhibitors Sensitize Human Non-small Cell Lung Cancer Cells to Ionizing Radiation Through Acetyl p53-Mediated c-myc Down-Regulation (English)

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Sung-Keum Seo

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hyeon-Ok Jin

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sang-Hyeok Woo

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Young-Sun Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sungkwan An

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jae-Ho Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Seok-Il Hong

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Kee-Ho Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tae-Boo Choe

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

In-Chul Park

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21642861

3 December 2024

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

August 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21642861

3 December 2024

full work available at URL

http://www.jto.org/article/S1556086415310583/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21642861

3 December 2024

https://api.elsevier.com/content/article/PII:S1556086415310583?httpAccept=text/xml

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

https://api.elsevier.com/content/article/PII:S1556086415310583?httpAccept=text/plain

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Journal of Thoracic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1313-1319

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells

1

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Rational development of histone deacetylase inhibitors as anticancer agents: a review

2

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Histone deacetylation as a target for radiosensitization

3

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Bmf contributes to histone deacetylase inhibitor-mediated enhancing effects on apoptosis after ionizing radiation

4

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition

5

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer

6

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors

7

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53.

8

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention

9

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

10

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases

11

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.

12

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).

13

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

14

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex

15

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

CD27 and CD40 inhibit p53-independent mitochondrial pathways in apoptosis of B cells induced by B cell receptor ligation

16

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts

17

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation

18

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Acetylation of p53 inhibits its ubiquitination by Mdm2.

19

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Acetylation is indispensable for p53 activation

20

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Regulation of programmed cell death by the p53 pathway.

21

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53.

22

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest

23

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity

24

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter

25

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Site-specific acetylation of p53 directs selective transcription complex assembly.

26

1 reference

10.1097/JTO.0B013E318220CAFF

https://api.crossref.org/works/10.1097/JTO.0B013E318220CAFF

3 December 2024

Identifiers

10.1097/JTO.0B013E318220CAFF

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39530259&oldid=2283203322"